Skip to main content
Clinical Trials/NCT03203395
NCT03203395
Completed
Not Applicable

Screening for Depression and Anxiety in Patients With Heart Disease

Diakonhjemmet Hospital0 sites232 target enrollmentJanuary 1, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Depression
Sponsor
Diakonhjemmet Hospital
Enrollment
232
Primary Endpoint
Detection of patients with or at risk for depression and/or anxiety disorders.
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Depression is a risk factor for morbidity and mortality in patients with heart disease, and has a negative impact on quality of life, work capacity and treatment adherence. Screening for depression among heart patients are therefore recommended by the Norwegian Health Authorities. Also, symptoms of anxiety may negatively affect rehabilitation due to e.g. fear of physical activity and excessive worry. Patients currently receiving treatment for heart disease at Diakonhjemmet Hospital will be screened for symptoms of depression and anxiety. If such symptoms are detected, patients will be offered a counselling session with a clinical psychologist. Further, routines for collaborative communication between clinical psychologist, cardiologist and the patient's general physician will be emphasized.

Registry
clinicaltrials.gov
Start Date
January 1, 2017
End Date
October 1, 2017
Last Updated
6 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Diakonhjemmet Hospital
Responsible Party
Principal Investigator
Principal Investigator

Torkil Berge

Academic Development Counselor

Diakonhjemmet Hospital

Eligibility Criteria

Inclusion Criteria

  • Men and women over 18 years under treatment for myocardial infarction, heart failure, tachyarrhythmia and/or valvular heart disease at the Department of Internal Medicine, Diakonhjemmet Hospital.

Exclusion Criteria

  • Unable to provide informed consent.
  • Unable to read and/or understand Norwegian.
  • Unable to complete a survey.

Outcomes

Primary Outcomes

Detection of patients with or at risk for depression and/or anxiety disorders.

Time Frame: 1 hour

Patients who screened positive for symptoms of depression, anxiety and/or panic attack will be asked to complete the Hospital Anxiety and Depression Scale (HADS). Patients with a HADS score of ≥ 4 will be offered a counselling session with a clinical psychologist.

Implementation of counselling for treatment and prevention of depression and anxiety disorders in heart patients.

Time Frame: 1-2 hours

Patients with a HADS score of ≥ 4 will be offered a counselling session with a clinical psychologist aimed to treat and prevent depression and anxiety disorders in heart patients.

Detection of symptoms of depression, anxiety and/or recent panic attack in heart patients.

Time Frame: 15 minutes

All patients included in the study will be screened for symptoms of depression, anxiety and recent panic attack by filling out a survey consisting of questions from the Patient Health Questionnaire-2 (PHQ-2), the Generalized Anxiety Disorder Scale-2 (GAD-2) and a question about whether they experienced a panic attack in the last four weeks. Cut-off is set to a score of ≥ 2 on PHQ-2 and/or GAD-2 and/or a positive answer on the question about panic attack.

Similar Trials